BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

272 related articles for article (PubMed ID: 38292478)

  • 1. Utilizing exosomes as sparking clinical biomarkers and therapeutic response in acute myeloid leukemia.
    Wang W; Wu X; Zheng J; Yin R; Li Y; Wu X; Xu L; Jin Z
    Front Immunol; 2023; 14():1315453. PubMed ID: 38292478
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of Acute Myeloid Leukemia (AML)-Derived exosomes in tumor progression and survival.
    Amin AH; Sharifi LMA; Kakhharov AJ; Opulencia MJC; Alsaikhan F; Bokov DO; Majdi HS; Jawad MA; Hammid AT; Shalaby MN; Mustafa YF; Siahmansouri H
    Biomed Pharmacother; 2022 Jun; 150():113009. PubMed ID: 35486974
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Acute myeloid leukemia transforms the bone marrow niche into a leukemia-permissive microenvironment through exosome secretion.
    Kumar B; Garcia M; Weng L; Jung X; Murakami JL; Hu X; McDonald T; Lin A; Kumar AR; DiGiusto DL; Stein AS; Pullarkat VA; Hui SK; Carlesso N; Kuo YH; Bhatia R; Marcucci G; Chen CC
    Leukemia; 2018 Mar; 32(3):575-587. PubMed ID: 28816238
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The role of exosomes in the stemness maintenance and progression of acute myeloid leukemia.
    Li Q; Wang M; Liu L
    Biochem Pharmacol; 2023 Jun; 212():115539. PubMed ID: 37024061
    [TBL] [Abstract][Full Text] [Related]  

  • 5. RNA trafficking by acute myelogenous leukemia exosomes.
    Huan J; Hornick NI; Shurtleff MJ; Skinner AM; Goloviznina NA; Roberts CT; Kurre P
    Cancer Res; 2013 Jan; 73(2):918-29. PubMed ID: 23149911
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Transforming the Niche: The Emerging Role of Extracellular Vesicles in Acute Myeloid Leukaemia Progression.
    Mendes M; Monteiro AC; Neto E; Barrias CC; Sobrinho-Simões MA; Duarte D; Caires HR
    Int J Mol Sci; 2024 Apr; 25(8):. PubMed ID: 38674015
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bone mesenchymal stem cell-derived exosomal microRNA-7-5p inhibits progression of acute myeloid leukemia by targeting OSBPL11.
    Jiang D; Wu X; Sun X; Tan W; Dai X; Xie Y; Du A; Zhao Q
    J Nanobiotechnology; 2022 Jan; 20(1):29. PubMed ID: 35012554
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Exosomes in acute myeloid leukemia inhibit hematopoiesis.
    Boyiadzis M; Whiteside TL
    Curr Opin Hematol; 2018 Jul; 25(4):279-284. PubMed ID: 29846239
    [TBL] [Abstract][Full Text] [Related]  

  • 9. EV-mediated intercellular communication in acute myeloid leukemia: Transport of genetic materials in the bone marrow microenvironment.
    Zhou Q; Li Z; Xi Y
    Exp Hematol; 2024 May; 133():104175. PubMed ID: 38311165
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Blasts in context: the impact of the immune environment on acute myeloid leukemia prognosis and treatment.
    Serroukh Y; Hébert J; Busque L; Mercier F; Rudd CE; Assouline S; Lachance S; Delisle JS
    Blood Rev; 2023 Jan; 57():100991. PubMed ID: 35941029
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Circulating cells and exosomes in acute myelogenous leukemia and their role in disease progression and survival.
    Miyamoto KN; Bonatto D
    Clin Immunol; 2020 Aug; 217():108489. PubMed ID: 32492479
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Exploiting epigenetically mediated changes: Acute myeloid leukemia, leukemia stem cells and the bone marrow microenvironment.
    Kogan AA; Lapidus RG; Baer MR; Rassool FV
    Adv Cancer Res; 2019; 141():213-253. PubMed ID: 30691684
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A novel therapeutic strategy: the significance of exosomal miRNAs in acute myeloid leukemia.
    Salehi A
    Med Oncol; 2024 Jan; 41(2):62. PubMed ID: 38253748
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Isolation and characterization of CD34+ blast-derived exosomes in acute myeloid leukemia.
    Hong CS; Muller L; Boyiadzis M; Whiteside TL
    PLoS One; 2014; 9(8):e103310. PubMed ID: 25093329
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of Acute Myeloid Leukemia Bone Marrow Circulating MicroRNAs.
    Moussa Agha D; Rouas R; Najar M; Bouhtit F; Naamane N; Fayyad-Kazan H; Bron D; Meuleman N; Lewalle P; Merimi M
    Int J Mol Sci; 2020 Sep; 21(19):. PubMed ID: 32992819
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Roles of the bone marrow niche in hematopoiesis, leukemogenesis, and chemotherapy resistance in acute myeloid leukemia.
    Wang A; Zhong H
    Hematology; 2018 Dec; 23(10):729-739. PubMed ID: 29902132
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A Role for the Bone Marrow Microenvironment in Drug Resistance of Acute Myeloid Leukemia.
    Bolandi SM; Pakjoo M; Beigi P; Kiani M; Allahgholipour A; Goudarzi N; Khorashad JS; Eiring AM
    Cells; 2021 Oct; 10(11):. PubMed ID: 34831055
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of Acute Myeloid Leukemia-derived Extracellular Vesicles on Bone Marrow Mesenchymal Stromal Cells: Expression of Poor Prognosis Genes.
    Kargar-Sichani Y; Mohammadi MH; Amiri V; Barzegar M; Keshavarz A; Bashash D; Farsani MA
    Arch Med Res; 2023 Feb; 54(2):95-104. PubMed ID: 36717322
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The role of exosomes and MYC in therapy resistance of acute myeloid leukemia: Challenges and opportunities.
    Mudgapalli N; Nallasamy P; Chava H; Chava S; Pathania AS; Gunda V; Gorantla S; Pandey MK; Gupta SC; Challagundla KB
    Mol Aspects Med; 2019 Dec; 70():21-32. PubMed ID: 31623866
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Small-sized extracellular vesicles (EVs) derived from acute myeloid leukemia bone marrow mesenchymal stem cells transfer miR-26a-5p to promote acute myeloid leukemia cell proliferation, migration, and invasion.
    Ji D; He Y; Lu W; Rong Y; Li F; Huang X; Huang R; Jiang Y; Chen G
    Hum Cell; 2021 May; 34(3):965-976. PubMed ID: 33620671
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.